PSG9 antibody (N-Term)
Quick Overview for PSG9 antibody (N-Term) (ABIN632496)
Target
See all PSG9 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- PSG9 antibody was raised against the N terminal of PSG9
-
Purification
- Affinity purified
-
Immunogen
- PSG9 antibody was raised using the N terminal of PSG9 corresponding to a region with amino acids YSNASLLIQNVTRKDAGTYTLHIIKRGDETREEIRHFTFTLYLETPKPYI
-
-
-
-
Application Notes
-
WB: 0.25 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
PSG9 Blocking Peptide, (ABIN936221), is also available for use as a blocking control in assays to test for specificity of this PSG9 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of PSG9 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- PSG9 (Pregnancy Specific beta-1-Glycoprotein 9 (PSG9))
-
Alternative Name
- PSG9
-
Background
- The human pregnancy-specific glycoproteins (PSGs) are a group of molecules that are mainly produced by the placental syncytiotrophoblasts during pregnancy. PSGs comprise a subgroup of the carcinoembryonic antigen (CEA) family, which belongs to the immunoglobulin superfamily.
-
Molecular Weight
- 54 kDa (MW of target protein)
Target
-